Critical event management provider OnSolve stated on Wednesday that the public health authorities are using its CodeRED product to communicate with citizens and first responders regarding the COVID-19 vaccine availability and immunization logistics across the US.
The company has established a public advisory to help government officials at the local, state and federal levels, as well healthcare organizations, including hospitals, maximize their efforts to effectively and safely organize their COVID-19 vaccination effort.
Currently, nearly 200 communities are using the company's CodeRed to manage the sharing of information related to COVID-19 vaccine deployment and nearly 640,000 messages related to vaccine deployment have been sent. They are leveraging CodeRED's rapid, tailored critical communications capabilities and easy integration with other emergency management solutions for this vital public health project.
In conjunction, Coles County Health Department in Charleston, Illinois will use the company's CodeRED emergency notification solution to communicate critical information related to COVID-19 vaccine deployment in the area.
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine
TransCode acquires Polynoma and secures USD25m investment from CK Life Sciences
Wasatch BioLabs adds three Oxford Nanopore-developed research-use-only assays to service portfolio